Reduction of tissue sodium content by SGLT-2-inhibition with dapagliflozin

28 August 2017 (16:48 - 16:57)
Organised by:
Congress Presentation Part of: Innovations in hypertension management and devices Treatment of hypertension ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by